Share Price and Basic Stock Data
Last Updated: January 10, 2026, 4:59 am
| PEG Ratio | -0.65 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Gujarat Narmada Valley Fertilizers & Chemicals Ltd (GNFC) operates in the fertilizers industry and has shown a varied revenue trajectory in recent years. For the fiscal year ending March 2023, GNFC reported sales of ₹10,227 Cr, marking a notable increase from ₹8,642 Cr in the previous year. However, preliminary figures for FY 2024 indicate a decline in sales to ₹7,930 Cr. Quarterly results reflect fluctuations, with the highest quarterly sales of ₹2,673 Cr recorded in December 2022, while the lowest was ₹1,652 Cr in June 2023. The most recent quarterly sales for September 2023 stood at ₹2,080 Cr, suggesting a recovery trend. Despite these variances, the year-on-year growth from ₹2,587 Cr in September 2022 to ₹2,080 Cr in September 2023 indicates resilience amid market challenges. The company’s ability to navigate through these fluctuations is critical, especially as the industry faces external pressures such as input costs and regulatory changes.
Profitability and Efficiency Metrics
GNFC’s profitability metrics reveal a mixed performance over the past fiscal years. The operating profit margin (OPM) for March 2023 was recorded at 18%, which is significantly higher than the 6% in March 2024 and 8% in March 2025. This decline in OPM is concerning, particularly as the company grappled with rising expenses, which reached ₹8,348 Cr in FY 2023 from ₹6,259 Cr in FY 2022. The net profit for FY 2023 was ₹1,464 Cr but fell to ₹485 Cr in FY 2024 before rebounding to ₹586 Cr in FY 2025. The interest coverage ratio (ICR) stood at a robust 48.63x, indicating strong earnings relative to interest obligations. However, the return on equity (ROE) and return on capital employed (ROCE) were relatively modest at 7.03% and 9.70%, respectively. These figures suggest that while GNFC maintains a solid interest coverage, its overall profitability and efficiency in capital utilization require improvement to align with sector benchmarks.
Balance Sheet Strength and Financial Ratios
The balance sheet of GNFC demonstrates significant strength, characterized by a low debt level of ₹13 Cr against total liabilities of ₹10,924 Cr as of March 2025, resulting in a total debt to equity ratio of just 0.01. This is markedly lower than the typical sector average, indicating a conservative financial approach. The company reported reserves of ₹8,371 Cr, providing a solid buffer for future investments and operational stability. Moreover, the price-to-book value (P/BV) ratio was recorded at 0.85x, indicating that the stock is trading below its book value, which may present a value proposition for investors. The current ratio of 4.67x and quick ratio of 3.57x are well above the typical industry standards, showcasing excellent liquidity and short-term financial health. However, the decline in net profit margins from 14.31% in FY 2023 to 7.41% in FY 2025 raises questions about operational efficiency moving forward.
Shareholding Pattern and Investor Confidence
GNFC’s shareholding pattern reflects a stable ownership structure, with promoters holding 41.30% of the equity as of December 2023. This level of promoter holding is consistent and indicates a strong commitment to the company’s long-term vision. Institutional investors, including foreign institutional investors (FIIs) at 12.08% and domestic institutional investors (DIIs) at 10.69%, demonstrate a moderate level of confidence in the company’s prospects. The public holds 35.92% of the shares, with the total number of shareholders reported at 2,75,857, suggesting a broad retail investor base. Over the past year, the FII stake has seen a decline, from 20.47% in December 2022 to 12.08% in September 2025, which may reflect concerns over recent performance. This shift indicates potential volatility in investor sentiment, necessitating the company to enhance its operational performance to regain confidence among institutional investors.
Outlook, Risks, and Final Insight
Looking ahead, GNFC faces both opportunities and challenges. Strengths include a robust balance sheet with minimal debt and a strong interest coverage ratio, positioning the company well for future growth. Additionally, the recovery in sales following recent lows could indicate a potential turnaround in operational performance. However, risks such as declining profit margins and fluctuating revenues pose significant challenges that require strategic management. The company must focus on improving operational efficiency and enhancing profitability to align with industry standards. Regulatory changes within the fertilizers sector may also impact operations and profitability. In the event of stable commodity prices and efficient cost management, GNFC could capitalize on growth opportunities. Conversely, continued operational inefficiencies and external market pressures could hinder performance, underscoring the importance of strategic agility in navigating the evolving landscape.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gujarat State Fertilizers & Chemicals Ltd | 7,062 Cr. | 177 | 221/156 | 10.6 | 313 | 2.82 % | 6.18 % | 4.77 % | 2.00 |
| Bharat Agri Fert & Realty Ltd | 148 Cr. | 28.0 | 73.0/26.5 | 9.97 | 0.00 % | 6.14 % | 14.8 % | 1.00 | |
| Basant Agro Tech (India) Ltd | 102 Cr. | 11.2 | 18.7/10.4 | 20.2 | 20.0 | 0.45 % | 6.52 % | 2.36 % | 1.00 |
| Zuari Agro Chemicals Ltd | 1,278 Cr. | 304 | 395/155 | 3.69 | 602 | 0.00 % | 12.7 % | 9.06 % | 10.0 |
| Southern Petrochemicals Industries Corporation Ltd (SPIC) | 1,589 Cr. | 78.0 | 128/66.2 | 8.55 | 63.8 | 2.56 % | 16.9 % | 13.8 % | 10.0 |
| Industry Average | 10,602.10 Cr | 387.62 | 48.68 | 185.72 | 0.98% | 13.03% | 10.58% | 6.96 |
All Competitor Stocks of Gujarat Narmada Valley Fertilizers & Chemicals Ltd
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,587 | 2,673 | 2,271 | 1,652 | 2,080 | 2,088 | 2,110 | 2,021 | 1,917 | 1,899 | 2,055 | 1,601 | 1,968 |
| Expenses | 2,278 | 2,235 | 1,902 | 1,547 | 1,911 | 2,004 | 1,965 | 1,868 | 1,827 | 1,767 | 1,815 | 1,570 | 1,783 |
| Operating Profit | 309 | 438 | 369 | 105 | 169 | 84 | 145 | 153 | 90 | 132 | 240 | 31 | 185 |
| OPM % | 12% | 16% | 16% | 6% | 8% | 4% | 7% | 8% | 5% | 7% | 12% | 2% | 9% |
| Other Income | 85 | 77 | 123 | 88 | 152 | 121 | 108 | 99 | 123 | 157 | 122 | 150 | 127 |
| Interest | 1 | 1 | 1 | 1 | 1 | 7 | 4 | 17 | 2 | 3 | 1 | 2 | 1 |
| Depreciation | 77 | 76 | 74 | 76 | 78 | 76 | 78 | 78 | 76 | 75 | 74 | 74 | 81 |
| Profit before tax | 316 | 438 | 417 | 116 | 242 | 122 | 171 | 157 | 135 | 211 | 287 | 105 | 230 |
| Tax % | 25% | 26% | 20% | 27% | 26% | 22% | 26% | 27% | 24% | 25% | 27% | 26% | 23% |
| Net Profit | 237 | 324 | 334 | 85 | 178 | 95 | 127 | 115 | 102 | 158 | 210 | 78 | 177 |
| EPS in Rs | 15.25 | 20.85 | 21.49 | 5.47 | 11.45 | 6.47 | 8.64 | 7.83 | 6.94 | 10.75 | 14.29 | 5.31 | 12.05 |
Last Updated: January 1, 2026, 1:16 pm
Below is a detailed analysis of the quarterly data for Gujarat Narmada Valley Fertilizers & Chemicals Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 1,968.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,601.00 Cr. (Jun 2025) to 1,968.00 Cr., marking an increase of 367.00 Cr..
- For Expenses, as of Sep 2025, the value is 1,783.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,570.00 Cr. (Jun 2025) to 1,783.00 Cr., marking an increase of 213.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 185.00 Cr.. The value appears strong and on an upward trend. It has increased from 31.00 Cr. (Jun 2025) to 185.00 Cr., marking an increase of 154.00 Cr..
- For OPM %, as of Sep 2025, the value is 9.00%. The value appears strong and on an upward trend. It has increased from 2.00% (Jun 2025) to 9.00%, marking an increase of 7.00%.
- For Other Income, as of Sep 2025, the value is 127.00 Cr.. The value appears to be declining and may need further review. It has decreased from 150.00 Cr. (Jun 2025) to 127.00 Cr., marking a decrease of 23.00 Cr..
- For Interest, as of Sep 2025, the value is 1.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 2.00 Cr. (Jun 2025) to 1.00 Cr., marking a decrease of 1.00 Cr..
- For Depreciation, as of Sep 2025, the value is 81.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 74.00 Cr. (Jun 2025) to 81.00 Cr., marking an increase of 7.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 230.00 Cr.. The value appears strong and on an upward trend. It has increased from 105.00 Cr. (Jun 2025) to 230.00 Cr., marking an increase of 125.00 Cr..
- For Tax %, as of Sep 2025, the value is 23.00%. The value appears to be improving (decreasing) as expected. It has decreased from 26.00% (Jun 2025) to 23.00%, marking a decrease of 3.00%.
- For Net Profit, as of Sep 2025, the value is 177.00 Cr.. The value appears strong and on an upward trend. It has increased from 78.00 Cr. (Jun 2025) to 177.00 Cr., marking an increase of 99.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 12.05. The value appears strong and on an upward trend. It has increased from 5.31 (Jun 2025) to 12.05, marking an increase of 6.74.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:17 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 4,847 | 4,642 | 4,552 | 4,589 | 5,837 | 5,896 | 5,162 | 5,129 | 8,642 | 10,227 | 7,930 | 7,892 | 7,523 |
| Expenses | 4,231 | 4,662 | 3,989 | 3,936 | 4,445 | 5,022 | 4,621 | 4,125 | 6,259 | 8,348 | 7,428 | 7,277 | 6,935 |
| Operating Profit | 616 | -21 | 563 | 653 | 1,392 | 874 | 542 | 1,003 | 2,384 | 1,879 | 502 | 615 | 588 |
| OPM % | 13% | -0% | 12% | 14% | 24% | 15% | 10% | 20% | 28% | 18% | 6% | 8% | 8% |
| Other Income | 45 | 52 | 252 | 517 | 140 | 215 | 153 | 237 | 209 | 361 | 469 | 501 | 556 |
| Interest | 92 | 274 | 297 | 203 | 100 | 6 | 5 | 20 | 3 | 5 | 13 | 23 | 7 |
| Depreciation | 145 | 209 | 251 | 251 | 270 | 263 | 264 | 272 | 292 | 303 | 308 | 303 | 304 |
| Profit before tax | 424 | -452 | 268 | 715 | 1,162 | 819 | 425 | 948 | 2,298 | 1,932 | 651 | 790 | 833 |
| Tax % | 31% | 0% | 35% | 27% | 32% | 10% | -17% | 27% | 26% | 24% | 26% | 26% | |
| Net Profit | 292 | -452 | 173 | 521 | 790 | 741 | 499 | 689 | 1,704 | 1,464 | 485 | 586 | 623 |
| EPS in Rs | 18.81 | -29.09 | 11.11 | 33.54 | 50.80 | 47.69 | 32.10 | 44.35 | 109.62 | 94.20 | 32.99 | 39.85 | 42.40 |
| Dividend Payout % | 19% | 0% | 18% | 15% | 15% | 15% | 16% | 18% | 9% | 32% | 50% | 45% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -254.79% | 138.27% | 201.16% | 51.63% | -6.20% | -32.66% | 38.08% | 147.31% | -14.08% | -66.87% | 20.82% |
| Change in YoY Net Profit Growth (%) | 0.00% | 393.07% | 62.88% | -149.52% | -57.83% | -26.46% | 70.73% | 109.24% | -161.40% | -52.79% | 87.70% |
Gujarat Narmada Valley Fertilizers & Chemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 9% |
| 3 Years: | -3% |
| TTM: | -10% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 3% |
| 3 Years: | -30% |
| TTM: | 6% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 25% |
| 5 Years: | 20% |
| 3 Years: | -11% |
| 1 Year: | -27% |
| Return on Equity | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 13% |
| 3 Years: | 10% |
| Last Year: | 7% |
Last Updated: September 5, 2025, 5:35 am
Balance Sheet
Last Updated: December 4, 2025, 1:20 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 155 | 155 | 155 | 155 | 155 | 155 | 155 | 155 | 155 | 155 | 147 | 147 | 147 |
| Reserves | 2,790 | 2,325 | 3,122 | 3,646 | 4,303 | 4,842 | 5,067 | 5,828 | 7,743 | 8,851 | 8,051 | 8,305 | 8,371 |
| Borrowings | 3,904 | 3,844 | 3,101 | 1,959 | 303 | 208 | 860 | 4 | 2 | 2 | 3 | 106 | 13 |
| Other Liabilities | 2,420 | 2,164 | 2,130 | 2,142 | 2,411 | 2,337 | 2,261 | 2,321 | 2,764 | 2,613 | 2,405 | 2,366 | 2,203 |
| Total Liabilities | 9,270 | 8,488 | 8,509 | 7,903 | 7,172 | 7,542 | 8,344 | 8,309 | 10,664 | 11,621 | 10,606 | 10,924 | 10,734 |
| Fixed Assets | 4,873 | 4,468 | 4,367 | 4,442 | 4,161 | 3,959 | 3,810 | 3,720 | 3,578 | 3,381 | 3,238 | 3,094 | 2,981 |
| CWIP | 23 | 13 | 9 | 14 | 14 | 25 | 82 | 161 | 138 | 187 | 289 | 382 | 754 |
| Investments | 132 | 145 | 729 | 762 | 726 | 732 | 596 | 853 | 1,222 | 3,106 | 2,919 | 2,181 | 2,240 |
| Other Assets | 4,241 | 3,861 | 3,404 | 2,683 | 2,271 | 2,826 | 3,856 | 3,575 | 5,727 | 4,946 | 4,160 | 5,268 | 4,759 |
| Total Assets | 9,270 | 8,488 | 8,509 | 7,903 | 7,172 | 7,542 | 8,344 | 8,309 | 10,664 | 11,621 | 10,606 | 10,924 | 10,734 |
Below is a detailed analysis of the balance sheet data for Gujarat Narmada Valley Fertilizers & Chemicals Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 147.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 147.00 Cr..
- For Reserves, as of Sep 2025, the value is 8,371.00 Cr.. The value appears strong and on an upward trend. It has increased from 8,305.00 Cr. (Mar 2025) to 8,371.00 Cr., marking an increase of 66.00 Cr..
- For Borrowings, as of Sep 2025, the value is 13.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 106.00 Cr. (Mar 2025) to 13.00 Cr., marking a decrease of 93.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 2,203.00 Cr.. The value appears to be improving (decreasing). It has decreased from 2,366.00 Cr. (Mar 2025) to 2,203.00 Cr., marking a decrease of 163.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 10,734.00 Cr.. The value appears to be improving (decreasing). It has decreased from 10,924.00 Cr. (Mar 2025) to 10,734.00 Cr., marking a decrease of 190.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 2,981.00 Cr.. The value appears to be declining and may need further review. It has decreased from 3,094.00 Cr. (Mar 2025) to 2,981.00 Cr., marking a decrease of 113.00 Cr..
- For CWIP, as of Sep 2025, the value is 754.00 Cr.. The value appears strong and on an upward trend. It has increased from 382.00 Cr. (Mar 2025) to 754.00 Cr., marking an increase of 372.00 Cr..
- For Investments, as of Sep 2025, the value is 2,240.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,181.00 Cr. (Mar 2025) to 2,240.00 Cr., marking an increase of 59.00 Cr..
- For Other Assets, as of Sep 2025, the value is 4,759.00 Cr.. The value appears to be declining and may need further review. It has decreased from 5,268.00 Cr. (Mar 2025) to 4,759.00 Cr., marking a decrease of 509.00 Cr..
- For Total Assets, as of Sep 2025, the value is 10,734.00 Cr.. The value appears to be declining and may need further review. It has decreased from 10,924.00 Cr. (Mar 2025) to 10,734.00 Cr., marking a decrease of 190.00 Cr..
Notably, the Reserves (8,371.00 Cr.) exceed the Borrowings (13.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 613.00 | -24.00 | 560.00 | 652.00 | -302.00 | 666.00 | -318.00 | -3.00 | 0.00 | -1.00 | 499.00 | 509.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 110 | 107 | 119 | 88 | 70 | 77 | 100 | 36 | 26 | 13 | 29 | 20 |
| Inventory Days | 99 | 98 | 107 | 110 | 98 | 106 | 125 | 129 | 91 | 84 | 94 | 105 |
| Days Payable | 35 | 39 | 40 | 57 | 61 | 50 | 68 | 63 | 59 | 42 | 42 | 40 |
| Cash Conversion Cycle | 173 | 166 | 186 | 142 | 107 | 132 | 156 | 103 | 58 | 55 | 81 | 84 |
| Working Capital Days | -7 | 9 | 8 | 27 | 57 | 76 | 117 | 68 | 97 | 46 | 58 | 61 |
| ROCE % | 8% | -3% | 9% | 10% | 24% | 17% | 8% | 16% | 33% | 23% | 8% | 10% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| ICICI Prudential Multi Asset Fund | 3,488,646 | 0.23 | 173.72 | 1,371,661 | 2025-12-07 23:08:50 | 154.34% |
| ICICI Prudential Smallcap Fund | 2,500,000 | 1.47 | 124.49 | 1,895,613 | 2025-12-07 05:36:57 | 31.88% |
| ICICI Prudential Large & Mid Cap Fund | 2,088,717 | 0.39 | 104.01 | 1,970,336 | 2025-12-15 01:51:32 | 6.01% |
| ICICI Prudential Multicap Fund | 1,594,139 | 0.49 | 79.38 | 1,092,557 | 2025-12-07 12:58:36 | 45.91% |
| ICICI Prudential Business Cycle Fund | 1,057,003 | 0.34 | 52.63 | N/A | N/A | N/A |
| ICICI Prudential Manufacturing Fund | 922,745 | 0.69 | 45.95 | 622,745 | 2025-12-07 20:47:36 | 48.17% |
| ICICI Prudential PSU Equity Fund | 213,942 | 0.55 | 10.65 | N/A | N/A | N/A |
| ICICI Prudential Commodities Fund | 200,000 | 0.31 | 9.96 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 40.68 | 32.47 | 94.68 | 110.05 | 44.84 |
| Diluted EPS (Rs.) | 40.68 | 32.47 | 94.68 | 110.05 | 44.84 |
| Cash EPS (Rs.) | 60.46 | 53.92 | 113.69 | 128.39 | 61.87 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 583.62 | 565.45 | 585.84 | 514.09 | 390.44 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 583.62 | 565.45 | 585.84 | 514.09 | 390.44 |
| Revenue From Operations / Share (Rs.) | 537.12 | 539.66 | 658.02 | 556.06 | 329.99 |
| PBDIT / Share (Rs.) | 75.96 | 66.09 | 144.11 | 166.85 | 79.82 |
| PBIT / Share (Rs.) | 55.35 | 45.16 | 124.62 | 148.08 | 62.30 |
| PBT / Share (Rs.) | 53.79 | 44.31 | 124.28 | 147.86 | 61.02 |
| Net Profit / Share (Rs.) | 39.85 | 32.99 | 94.19 | 109.62 | 44.34 |
| NP After MI And SOA / Share (Rs.) | 40.68 | 33.83 | 94.68 | 110.05 | 44.84 |
| PBDIT Margin (%) | 14.14 | 12.24 | 21.90 | 30.00 | 24.18 |
| PBIT Margin (%) | 10.30 | 8.36 | 18.93 | 26.63 | 18.87 |
| PBT Margin (%) | 10.01 | 8.21 | 18.88 | 26.59 | 18.49 |
| Net Profit Margin (%) | 7.41 | 6.11 | 14.31 | 19.71 | 13.43 |
| NP After MI And SOA Margin (%) | 7.57 | 6.26 | 14.38 | 19.79 | 13.58 |
| Return on Networth / Equity (%) | 6.97 | 5.98 | 16.16 | 21.40 | 11.48 |
| Return on Capital Employeed (%) | 8.25 | 6.91 | 18.61 | 24.57 | 13.04 |
| Return On Assets (%) | 5.43 | 4.65 | 12.58 | 15.95 | 8.31 |
| Total Debt / Equity (X) | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover Ratio (%) | 0.72 | 0.70 | 0.91 | 0.90 | 0.61 |
| Current Ratio (X) | 4.67 | 4.14 | 3.77 | 3.61 | 3.57 |
| Quick Ratio (X) | 3.57 | 3.11 | 2.90 | 2.89 | 2.73 |
| Inventory Turnover Ratio (X) | 6.64 | 5.25 | 6.66 | 5.60 | 3.43 |
| Dividend Payout Ratio (NP) (%) | 40.55 | 93.80 | 10.56 | 7.26 | 11.15 |
| Dividend Payout Ratio (CP) (%) | 26.92 | 57.94 | 8.75 | 6.21 | 8.01 |
| Earning Retention Ratio (%) | 59.45 | 6.20 | 89.44 | 92.74 | 88.85 |
| Cash Earning Retention Ratio (%) | 73.08 | 42.06 | 91.25 | 93.79 | 91.99 |
| Interest Coverage Ratio (X) | 48.63 | 77.57 | 425.81 | 749.48 | 62.18 |
| Interest Coverage Ratio (Post Tax) (X) | 26.51 | 39.72 | 279.32 | 493.41 | 35.55 |
| Enterprise Value (Cr.) | 5084.86 | 7652.47 | 5923.19 | 11944.13 | 3224.13 |
| EV / Net Operating Revenue (X) | 0.64 | 0.96 | 0.57 | 1.38 | 0.62 |
| EV / EBITDA (X) | 4.56 | 7.88 | 2.64 | 4.61 | 2.60 |
| MarketCap / Net Operating Revenue (X) | 0.92 | 1.16 | 0.77 | 1.52 | 0.91 |
| Retention Ratios (%) | 59.44 | 6.19 | 89.43 | 92.73 | 88.84 |
| Price / BV (X) | 0.85 | 1.10 | 0.86 | 1.64 | 0.77 |
| Price / Net Operating Revenue (X) | 0.92 | 1.16 | 0.77 | 1.52 | 0.91 |
| EarningsYield | 0.08 | 0.05 | 0.18 | 0.13 | 0.14 |
After reviewing the key financial ratios for Gujarat Narmada Valley Fertilizers & Chemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 40.68. This value is within the healthy range. It has increased from 32.47 (Mar 24) to 40.68, marking an increase of 8.21.
- For Diluted EPS (Rs.), as of Mar 25, the value is 40.68. This value is within the healthy range. It has increased from 32.47 (Mar 24) to 40.68, marking an increase of 8.21.
- For Cash EPS (Rs.), as of Mar 25, the value is 60.46. This value is within the healthy range. It has increased from 53.92 (Mar 24) to 60.46, marking an increase of 6.54.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 583.62. It has increased from 565.45 (Mar 24) to 583.62, marking an increase of 18.17.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 583.62. It has increased from 565.45 (Mar 24) to 583.62, marking an increase of 18.17.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 537.12. It has decreased from 539.66 (Mar 24) to 537.12, marking a decrease of 2.54.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 75.96. This value is within the healthy range. It has increased from 66.09 (Mar 24) to 75.96, marking an increase of 9.87.
- For PBIT / Share (Rs.), as of Mar 25, the value is 55.35. This value is within the healthy range. It has increased from 45.16 (Mar 24) to 55.35, marking an increase of 10.19.
- For PBT / Share (Rs.), as of Mar 25, the value is 53.79. This value is within the healthy range. It has increased from 44.31 (Mar 24) to 53.79, marking an increase of 9.48.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 39.85. This value is within the healthy range. It has increased from 32.99 (Mar 24) to 39.85, marking an increase of 6.86.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 40.68. This value is within the healthy range. It has increased from 33.83 (Mar 24) to 40.68, marking an increase of 6.85.
- For PBDIT Margin (%), as of Mar 25, the value is 14.14. This value is within the healthy range. It has increased from 12.24 (Mar 24) to 14.14, marking an increase of 1.90.
- For PBIT Margin (%), as of Mar 25, the value is 10.30. This value is within the healthy range. It has increased from 8.36 (Mar 24) to 10.30, marking an increase of 1.94.
- For PBT Margin (%), as of Mar 25, the value is 10.01. This value is within the healthy range. It has increased from 8.21 (Mar 24) to 10.01, marking an increase of 1.80.
- For Net Profit Margin (%), as of Mar 25, the value is 7.41. This value is within the healthy range. It has increased from 6.11 (Mar 24) to 7.41, marking an increase of 1.30.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 7.57. This value is below the healthy minimum of 8. It has increased from 6.26 (Mar 24) to 7.57, marking an increase of 1.31.
- For Return on Networth / Equity (%), as of Mar 25, the value is 6.97. This value is below the healthy minimum of 15. It has increased from 5.98 (Mar 24) to 6.97, marking an increase of 0.99.
- For Return on Capital Employeed (%), as of Mar 25, the value is 8.25. This value is below the healthy minimum of 10. It has increased from 6.91 (Mar 24) to 8.25, marking an increase of 1.34.
- For Return On Assets (%), as of Mar 25, the value is 5.43. This value is within the healthy range. It has increased from 4.65 (Mar 24) to 5.43, marking an increase of 0.78.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.01. This value is within the healthy range. It has increased from 0.00 (Mar 24) to 0.01, marking an increase of 0.01.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.72. It has increased from 0.70 (Mar 24) to 0.72, marking an increase of 0.02.
- For Current Ratio (X), as of Mar 25, the value is 4.67. This value exceeds the healthy maximum of 3. It has increased from 4.14 (Mar 24) to 4.67, marking an increase of 0.53.
- For Quick Ratio (X), as of Mar 25, the value is 3.57. This value exceeds the healthy maximum of 2. It has increased from 3.11 (Mar 24) to 3.57, marking an increase of 0.46.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 6.64. This value is within the healthy range. It has increased from 5.25 (Mar 24) to 6.64, marking an increase of 1.39.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 40.55. This value is within the healthy range. It has decreased from 93.80 (Mar 24) to 40.55, marking a decrease of 53.25.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 26.92. This value is within the healthy range. It has decreased from 57.94 (Mar 24) to 26.92, marking a decrease of 31.02.
- For Earning Retention Ratio (%), as of Mar 25, the value is 59.45. This value is within the healthy range. It has increased from 6.20 (Mar 24) to 59.45, marking an increase of 53.25.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 73.08. This value exceeds the healthy maximum of 70. It has increased from 42.06 (Mar 24) to 73.08, marking an increase of 31.02.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 48.63. This value is within the healthy range. It has decreased from 77.57 (Mar 24) to 48.63, marking a decrease of 28.94.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 26.51. This value is within the healthy range. It has decreased from 39.72 (Mar 24) to 26.51, marking a decrease of 13.21.
- For Enterprise Value (Cr.), as of Mar 25, the value is 5,084.86. It has decreased from 7,652.47 (Mar 24) to 5,084.86, marking a decrease of 2,567.61.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.64. This value is below the healthy minimum of 1. It has decreased from 0.96 (Mar 24) to 0.64, marking a decrease of 0.32.
- For EV / EBITDA (X), as of Mar 25, the value is 4.56. This value is below the healthy minimum of 5. It has decreased from 7.88 (Mar 24) to 4.56, marking a decrease of 3.32.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.92. This value is below the healthy minimum of 1. It has decreased from 1.16 (Mar 24) to 0.92, marking a decrease of 0.24.
- For Retention Ratios (%), as of Mar 25, the value is 59.44. This value is within the healthy range. It has increased from 6.19 (Mar 24) to 59.44, marking an increase of 53.25.
- For Price / BV (X), as of Mar 25, the value is 0.85. This value is below the healthy minimum of 1. It has decreased from 1.10 (Mar 24) to 0.85, marking a decrease of 0.25.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.92. This value is below the healthy minimum of 1. It has decreased from 1.16 (Mar 24) to 0.92, marking a decrease of 0.24.
- For EarningsYield, as of Mar 25, the value is 0.08. This value is below the healthy minimum of 5. It has increased from 0.05 (Mar 24) to 0.08, marking an increase of 0.03.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Gujarat Narmada Valley Fertilizers & Chemicals Ltd:
- Net Profit Margin: 7.41%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 8.25% (Industry Average ROCE: 13.03%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 6.97% (Industry Average ROE: 10.58%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 26.51
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 3.57
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 11.3 (Industry average Stock P/E: 48.68)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.01
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 7.41%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Fertilisers | P.O: Narmadanagar, Bharuch District Gujarat 392015 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Pankaj Joshi | Chairman |
| Dr. T Natarajan | Managing Director |
| Prof. Ranjan Kumar Ghosh | Independent Director |
| Mr. Bhadresh Mehta | Independent Director |
| Dr. N Ravichandran | Independent Director |
| Mr. Kamal Dayani | Director |
| Mrs. Gauri Kumar | Independent Woman Director |
| Mr. S J Haider | Director |
| Mr. Ajai Bahadur Khare | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Gujarat Narmada Valley Fertilizers & Chemicals Ltd?
Gujarat Narmada Valley Fertilizers & Chemicals Ltd's intrinsic value (as of 10 January 2026) is ₹382.46 which is 20.15% lower the current market price of ₹479.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹7,036 Cr. market cap, FY2025-2026 high/low of ₹585/449, reserves of ₹8,371 Cr, and liabilities of ₹10,734 Cr.
What is the Market Cap of Gujarat Narmada Valley Fertilizers & Chemicals Ltd?
The Market Cap of Gujarat Narmada Valley Fertilizers & Chemicals Ltd is 7,036 Cr..
What is the current Stock Price of Gujarat Narmada Valley Fertilizers & Chemicals Ltd as on 10 January 2026?
The current stock price of Gujarat Narmada Valley Fertilizers & Chemicals Ltd as on 10 January 2026 is ₹479.
What is the High / Low of Gujarat Narmada Valley Fertilizers & Chemicals Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Gujarat Narmada Valley Fertilizers & Chemicals Ltd stocks is ₹585/449.
What is the Stock P/E of Gujarat Narmada Valley Fertilizers & Chemicals Ltd?
The Stock P/E of Gujarat Narmada Valley Fertilizers & Chemicals Ltd is 11.3.
What is the Book Value of Gujarat Narmada Valley Fertilizers & Chemicals Ltd?
The Book Value of Gujarat Narmada Valley Fertilizers & Chemicals Ltd is 580.
What is the Dividend Yield of Gujarat Narmada Valley Fertilizers & Chemicals Ltd?
The Dividend Yield of Gujarat Narmada Valley Fertilizers & Chemicals Ltd is 3.76 %.
What is the ROCE of Gujarat Narmada Valley Fertilizers & Chemicals Ltd?
The ROCE of Gujarat Narmada Valley Fertilizers & Chemicals Ltd is 9.70 %.
What is the ROE of Gujarat Narmada Valley Fertilizers & Chemicals Ltd?
The ROE of Gujarat Narmada Valley Fertilizers & Chemicals Ltd is 7.03 %.
What is the Face Value of Gujarat Narmada Valley Fertilizers & Chemicals Ltd?
The Face Value of Gujarat Narmada Valley Fertilizers & Chemicals Ltd is 10.0.